Loading the security overview…
Where the tokens are
What Novartis AG has filed with the US Securities and Exchange Commission: annual and quarterly reports, current reports of material events, and the forms insiders file when they trade. Each links to the filing’s page on SEC.gov.
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Sep 8, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Sep 4, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Sep 1, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Jul 21, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Jun 11, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Apr 28, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Mar 18, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Feb 4, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Feb 4, 2026 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Feb 4, 2026 | 20-F | Annual report (foreign issuer) | On SEC.gov |
| Nov 25, 2025 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Nov 20, 2025 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Nov 5, 2025 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Oct 28, 2025 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Oct 27, 2025 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Sep 30, 2025 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Aug 11, 2025 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Jul 17, 2025 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Jul 17, 2025 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Jun 2, 2025 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Apr 29, 2025 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Apr 3, 2025 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Mar 28, 2025 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Jan 31, 2025 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Jan 31, 2025 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Jan 31, 2025 | 20-F | Annual report (foreign issuer) | On SEC.gov |
| Dec 30, 2024 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Nov 25, 2024 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Oct 29, 2024 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Oct 29, 2024 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Sep 18, 2024 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Sep 17, 2024 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Aug 8, 2024 | 6-K | Current report (foreign issuer) | On SEC.gov |
| Jul 18, 2024 | 6-K | Current report (foreign issuer) | On SEC.gov |
Figures describe Novartis AG shares, not any token. As of Sep 8, 2026, from EDGAR, via Massive. Token issuers file nothing here about the company; their own disclosures are on their issuer pages.